These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4064065)

  • 1. [Effect of ibopamine on the renal functional response to extracellular volume expansion in man].
    Agnoli GC; Cacciari M; Cariani A; Garutti C; Ikonomu E; Lenzi P
    Cardiologia; 1985 Feb; 30(2):129-37. PubMed ID: 4064065
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ibopamine, adrenolytic drugs and renal function].
    Agnoli GC; Borgatti R; Cacciari M; Dorigoni S; Garutti C; Ikonomu E; Lenzi P
    Minerva Cardioangiol; 1987 May; 35(5):241-50. PubMed ID: 2888053
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of effect of ibopamine, a dopamine pro-drug, on renal function in normal subjects.
    Harvey JN; Worth DP; Brown J; Lee MR
    Br J Clin Pharmacol; 1984 Jun; 17(6):671-7. PubMed ID: 6378230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation by strain gauge plethysmography of the effect of the acute administration of ibopamine on the peripheral circulation in the normal subject].
    Longhini C; Ansani L; Musacci GF; Fratti D; Toselli T; Lupato L
    Cardiologia; 1982 Dec; 27(12):1189-95. PubMed ID: 6892404
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interference of sulpiride on the effects of ibopamine at the level of peripheral circulation].
    Musacci GF; Longhini C; Ansani L; Artioli M; Dell'Acqua G; Fratti D
    Cardiologia; 1982 Dec; 27(12):1163-9. PubMed ID: 6892401
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of ibopamine on the peripheral circulation in the normal subject after protracted administration].
    Musacci GF; Longhini C; Ansani L; Toselli T; Pinca L; Dell'Acqua G
    Cardiologia; 1982 Dec; 27(12):1171-5. PubMed ID: 6892402
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term treatment of chronic renal insufficiency with Ibopamine (SB 7505), a new orally active dopamine-related drug.
    Stefoni S; Docci D; Vangelista A; Mosconi G; Colí L; Prandini R
    Clin Nephrol; 1982 Oct; 18(4):168-73. PubMed ID: 6754197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure.
    Musacci GF; Ansani L; Toselli T; Aggio S; Baracca E; Longhini C
    Arzneimittelforschung; 1986 Feb; 36(2A):380-2. PubMed ID: 3707654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ibopamine on the progression of chronic renal failure.
    Docci D; Pistocchi E; Turci F; Baldrati L
    Clin Nephrol; 1986 Sep; 26(3):121-4. PubMed ID: 3769226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic effects induced by ibopamine in myocardiopathy patients].
    Dei Cas L; Cucchini F; Bolognesi R; Fappani A; Manca C; Riva S
    Cardiologia; 1982; 27(6):601-2. PubMed ID: 6234903
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blood levels of activated renin, aldosterone, catecholamine in congestive heart failure. II. Effects of dopaminergic stimulation with a dopamine agonist: ibopamine].
    Melloni R; Scarazatti E; Gandini C; Melloni GF
    Boll Soc Ital Biol Sper; 1987 Dec; 63(12):1121-8. PubMed ID: 3331290
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind haemodynamic study of a new dopamine derivative (diisobutyric ester of N-methyl-dopamine) orally active in chronic congestive heart failure.
    Mengeot P; Piette F; Mirgaux M
    G Ital Cardiol; 1981; 11(11):1738-42. PubMed ID: 7343377
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary evaluation of the effect of ibopamine on the secretion of prolactin].
    Scarazzati E; Catenazzo G; Melloni CF; Ghirardi P; Bianco L
    Boll Soc Ital Biol Sper; 1983 Nov; 59(11):1631-5. PubMed ID: 6667307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary vascular activity of the novel inotropic pro-drug ibopamine and the de-esterified active form epinine.
    Ohlstein EH; Kopia GA; Ruffolo RR
    Arzneimittelforschung; 1988 Dec; 38(12):1790-2. PubMed ID: 3245851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effect of SB 7505: a double-blind study.
    Melloni GF; Minoja GM; Scorazzati G; Bauer R; Brusoni B; Ghirardi P
    Eur J Clin Pharmacol; 1981 Feb; 19(3):177-80. PubMed ID: 7011819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of plasma cholinesterase prevents the dopamine DA-1 receptor mediated renal vasodilation produced by ibopamine.
    Nichols AJ; Shebuski RJ; Ruffolo RR
    Eur J Pharmacol; 1987 Sep; 141(3):515-8. PubMed ID: 3666046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Strain gauge plethysmography in the evaluation of the effect of acute administration of ibopamine on the peripheral circulation of normal subjects].
    Longhini C; Ansani L; Musacci GF; Fratti D; Toselli T; Lupato L
    Cardiologia; 1982 Dec; 27(12):1189-95. PubMed ID: 6927477
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of ibopamine on changes in renal hemodynamics experimentally induced in anesthetized dogs].
    Merlo L; Brusoni B; Mussini E; Ghirardi P
    Boll Soc Ital Cardiol; 1981; 26(11):1569-75. PubMed ID: 7349207
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of ibopamine on the peripheral circulation of normal subjects after protracted administration].
    Musacci GF; Longhini C; Ansani L; Toselli T; Pinca L; Dell'Acqua G
    Cardiologia; 1982 Dec; 27(12):1171-5. PubMed ID: 6927475
    [No Abstract]   [Full Text] [Related]  

  • 20. Total and intrarenal flow distribution in healthy subjects: technique, acute effects of ibopamine and of indoramin.
    Britton KE; Nawaz MK; Nimmon CC; Mlodkowska E; Carroll M; Horne T; Granowska M
    Nephron; 1986; 43(4):265-73. PubMed ID: 3736737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.